Management Antiepileptic Drug Therapy – Goal: completely prevent seizures without causing untoward side effects Treat the underlying conditions – Reverse.

Slides:



Advertisements
Similar presentations
Anticonvulsants David G. Standaert, MD, PhD Massachusetts General Hospital Harvard Medical School.
Advertisements

Antiepileptic Drugs.
NEWLY DIAGNOSED EPILEPSY Treatment response in mesial temporal lobe epilepsy with hippocampal atrophy (N=14; 2.5% population) Non-responders (42%) Remission.
Update on Anti-platelets Gabriel A. Vidal, MD Vascular Neurology Ochsner Medical Center October 14 th, 2009.
Epilepsy 5.Year Prof.Dr.S.Naz Yeni.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 24 Drugs for Epilepsy.
Gregory Bergey, MD, FAAN ED Seizure and SE Patient Management: A Neurologist’s Perspective on Rx Objectives & AED Use.
Martha J. Morrell MD NeuroPace, Inc.
Canadian Cardiovascular Society Antiplatelet Guidelines
© 2014 Direct One Communications, Inc. All rights reserved. 1 Treating the New-Onset Epilepsy Patient Ching Y. Tsao, MD Emory University Hospital, Atlanta,
CAPRIE: Clopidogrel versus Aspirin in Patients at risk of Ischemic Events Purpose To assess the relative efficacy of the antiplatelet drugs clopidogrel.
Febrile convulsions. Meest frequente vorm van epilepsie bij kinderen Koortsstuipen = Febriele convulsies Is een vorm van (gegeneraliseerde) epilepsie.
EPILEPSY Review of new treatments and Recommendations.
Eduardo Garcia, MD Assistant Clinical Professor
Anti Epileptic Drugs (AEDs) Sampath Charya, MD, FAAN, FAASM VAMC, Fayetteville, NC.
Jonathan A. Edlow, MD, FACEP Transient Ischemic Attack Patient Update: The Optimal Management of Emergency Department Patients With Suspected Cerebral.
1 Lotronex ® (alosetron HCl) Tablets Risk-Benefit Issues Victor F. C. Raczkowski, M.D. Director, Division of Gastrointestinal and Coagulation Drug Products.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 16 Anticonvulsants.
Definition The epilepsies are a group of disorders characterized by chronic recurrent paroxysmal changes in neurologic function caused by abnormalities.
305 Study Randomised, Double Blind, Placebo Controlled Phase III Safety and Efficacy Study (8 and 12 mg OD) Conducted in Europe, Asia, North America, Australia,
Seizures Victoria Elliot. Outline Brief recap Management update Advantages and disadvantages of common antiepileptics Status epilepticus DVLA guidelines.
Can We Meet the Challenge? Raymond Tallis FRCP FMedSci SIG Meeting1.
DR ZULFIQAR ALI RIZVI CONSULTANT PSYCHIATRIST PIMH LAHORE.
Mosby items and derived items © 2005, 2002 by Mosby, Inc. CHAPTER 13 Antiepileptic Agents.
© 2012 Direct One Communications, Inc. All rights reserved. 1 Potential New Measures to Manage Partial-Onset Seizures David Wolf, MD, PhD Johns Hopkins.
Epilepsy update Martin Sadler. Issues Who to treat and when to start? Who needs investigations? What to start with? Treatment aims New drugs What to do.
Epilepsy Key slides Saint Valentine- Patron Saint of Epilepsy, martyred for the sake of love.
Slide 1 EZT 2002-W-6022-SS Ezetimibe Co-administered with Statins: Efficacy and Tolerability Copyright © 2003 MSP Singapore Company, LLC. All rights reserved.
Treatment. DEPENDS on the underlying cause Metabolic : correction Structural abnormality: seizure control + consider surgery Tumor Vascular Idiopathic.
Investigational Drugs in the hospital. + What is Investigational Drug? Investigational or experimental drugs are new drugs that have not yet been approved.
AIRE: Acute Infarction Ramipril Efficacy study Purpose To determine whether the ACE inhibitor ramipril reduces mortality in patients with evidence of heart.
EPILEPSY BY Prof. AZZA El- Medany. ETIOLOGY Congenital defects Head injuries Trauma Hypoxia Infections Brain tumor Drug withdrawal.
Anticonvulsant Therapy for Traumatic Brain Injury
HOPE: Heart Outcomes Prevention Evaluation study Purpose To evaluate whether the long-acting ACE inhibitor ramipril and/or vitamin E reduce the incidence.
Clinical Overview Director, Stanford Stroke Center Stanford University Palo Alto, California Gregory W. Albers, MD.
Treatment Resistant Pediatric BD Elham Shirazi M.D. Board of General Psychiatry Board of Child & Adolescent Psychiatry.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 13 Antiepileptic Drugs.
A Review of – Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Ted Williams Pharm D Candidate Monday Lab.
Management Antiepileptic Drug Therapy – Goal: completely prevent seizures without causing untoward side effects Treat the underlying conditions – Reverse.
Long-Term Tolerability of Ticagrelor for Secondary Prevention: Insights from PEGASUS-TIMI 54 Trial Marc P. Bonaca, MD, MPH on behalf of the PEGASUS-TIMI.
Long-Term Tolerability of Ticagrelor for Secondary Prevention: Insights from PEGASUS-TIMI 54 Trial Marc P. Bonaca, MD, MPH on behalf of the PEGASUS-TIMI.
RSS Merseyside Meeting, 26 February 2016: Pharmaceutical Statistics Sarah J. Nolan Department of Biostatistics University of Liverpool,
Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy 서울대병원 신경과 R3 김성헌.
ALLIE PUNKE PHARMACOKINETICS: ANTIEPILEPTIC DRUGS.
The term epilepsy refers to a group of disorders characterized by excessive excitability of neurons within the CNS. This abnormal activity can produce.
© 2016 Direct One Communications, Inc. All rights reserved. 1 Recent Research Expands Our Understanding of Perampanel Christian M. Cabrera Kang, MD Emory.
Journal Club Neuropsychological effects of levetiracetam and carbamazepine in children with focal epilepsy. Rebecca Luke 2/9/2016.
Seizure Disorders Tiara Lintoco Batch 8. Seizure Disorders Seizures are symptoms of an abnormality in the nerve centers of the brain. Also known as convulsions,
Switching to Generic Antiepileptic Drugs (AEDs)
Anticonvulsants By Alaina Darby.
Long term effectiveness of perampanel: the Leeds experience Jo Geldard, Melissa Maguire, Elizabeth Wright, Peter Goulding Leeds General Infirmary, Leeds.
Lecture 2 Dr.Narmin Hussen
HOPE: Heart Outcomes Prevention Evaluation study
Seizures in Childhood A seizure: is a transient occurrence of signs and/or symptoms resulting from abnormal excessive or synchronous neuronal activity.
Epilepsy and Niazy B Hussam Aldin.
Consultant Neurologist and Epileptologist
One of the oldest Known conditions
Antiepileptic Drugs: Pitting the Old Against the New
The Side Effects of Anti-Epileptic Drugs
Management of Patients with Epilepsy
To Titrate or Not: Optimizing Treatment With Antiepileptic Drugs
Seizures and Epilepsy: Introduction
Figure 2 Cumulative proportion of patients experiencing a seizure recurrence after randomization, comparing immediate vs deferred treatment Cumulative.
Panelists. One Size May Not Fit All: A New Aspirin Option for the High-Risk Patient.
Evidenced Based Journal Club – 20th June 2007
School of Pharmacy, University of Nizwa
Evaluation and Management of Pediatric Seizures
“Anti Epileptic Drugs II”
Presentation transcript:

Management Antiepileptic Drug Therapy – Goal: completely prevent seizures without causing untoward side effects Treat the underlying conditions – Reverse the problem and prevent its recurrence

Medical Management Current Perspectives in Epilepsy Treatment: Focus on Monotherapy, 2006 – Initial treatment of epilepsy should begin with AED monotherapy – If initial trial fails, try monotherapy with a second AED – Combination therapy should be considered only if the patient fails at least 2 monotherapy trials Pellock, John, and Michael Privitera. Current Perspectives in Epilepsy Treatment: Focus on Monotherapy. CME Discovery, USA: ArcMesa Educators and Scinexa, LLC., 2006.

Drugs of Choice for Adults with Partial Seizure Ropper, Allan, and Robert Brown. Adams and Victor's Principles of Neurology. 8th. McGraw-Hill, Phenytoin, carbamazepine, and valproate equally effective in the treatment of both generalized and partial seizures Phenytoin – Idiosyncratic phenytoin hypersensitivity – similar therapeutic and side-effect profile with valproate Carbamazepine preferred as initial drug because of fewer side effects Initial ChoiceSecond Choice CarbamazepineValproate PhenytoinLamotrigine Oxcarbazepine

Drug of Choice for Elderly Adults with Partial-Onset Seizures ILAE Treatment Guidelines, 2006 Based on available efficacy and effectiveness evidence alone, LTG and GBP are established as efficacious or effective as initial monotherapy for elderly adults with newly diagnosed or untreated partial-onset seizures (level A) Glauser, T, Elinor BM, Blaise Bs, et. al. "ILAE Treatment Guidelines: Evidence-based Analysis of Antiepileptic Drug Efficacy and Effectiveness as Initial Monotherapy for Epileptic Seizures and Syndromes." (International League Against Epilepsy) 27, no. 7 (2006):

Drug of Choice for Elderly Adults with Partial-Onset Seizures ILAE Treatment Guidelines, 2006 – Class I Trial Efficacy: CBZ = LTG and GBP Effectiveness: LTG and GBP>> CBZ

An International Multicenter Randomized Double-Blind Controlled Trial of Lamotrigine and Sustained-Release Carbamazepine in the Treatment of Newly Diagnosed Epilepsy in the Elderly (Satre, Erik, et al., 2007) P: Patients aged 65 years or older, who had experienced at least two unprovoked partial and/or generalized tonic– clonic seizures I: LTG (n = 93) or CBZ (n = 92) – 40-week treatment period: initial 4-week dose escalation phase and a 36-week maintenance phase

An International Multicenter Randomized Double-Blind Controlled Trial of Lamotrigine and Sustained-Release Carbamazepine in the Treatment of Newly Diagnosed Epilepsy in the Elderly (Satre, Erik, et al., 2007) O: – In the LTG group, 68 patients (73%) completed the 40- week study period compared with 61 (67%) in the CBZ group – Higher seizure-free rates for CBZ 46 (75%) than LTG 37 (54%) [OR=0.39, p=0.0129, CI to 0.83] in the per-protocol analysis – Better tolerability for LTG where 13 patients (14%) withdrew due to AEs in the LTG group, compared with 23 (25%) in the CBZ group M: Randomized Double-Blind Controlled Trial Saetre, Erik, et al. "An International Multicenter Randomized Double-Blind Controlled Trial of Lamotrigine and Sustained-Release Carbamazepine in the Treatment of Newly Diagnosed Epilepsy in the Elderly." Epilepsia 48.7 (2007):

Carbamazepine Many side effects Leukopenia is common Rare instances of pancytopenia,hyponatremia, and diabetes insipidus as idiosyncratic reactions. CBC should be done before treatment – white cell count should be checked regularly Ropper, Allan, and Robert Brown. Adams and Victor's Principles of Neurology. 8th. McGraw-Hill, 2005.

Lamotrigine – closely resembles phenytoin – less risk of teratogenic effects – selectively blocks the slow sodium channel  prevent release of glutamate and aspartate – effective as a first-line and adjunctive drug for generalized and focal seizure Ropper, Allan, and Robert Brown. Adams and Victor's Principles of Neurology. 8th. McGraw-Hill, 2005.

Gabapentin chemically similar to GABA enhances the intrinsic inhibitory system of GABA in the brain anticonvulsant mechanism is not known moderately effective in partial and secondary generalized seizures not metabolized by the liver Ropper, Allan, and Robert Brown. Adams and Victor's Principles of Neurology. 8th. McGraw-Hill, 2005.

Carbamazepine vs. Lamotrigine CarbamazepineLamotrigine EfficacyCBZ=LTG EffectivenessCBZ < LTG ✓ TolerabilityCBZ < LTG ✓ Cost From Maintenance: 800 mg-1.2 g daily in divided dose or up to 2 g daily Epazin CR 200mg/tab: Php 20.2/tab x 4 = Php80 daily Maintenance: mg/day once a day or in 2 divided doses Lamictal 100mg/tab: Php63/tab x 1 = Php63 daily CBZ <<< LTG

Post-stroke Maintenance Medications International Stroke Trial (IST, Lancet 1997;349: ) – Aspirin treated patients had slightly fewer deaths at 14 days, significantly fewer recurrent ischemic strokes at 14 days and no excess of hemorrhagic strokes

Post-stroke Maintenance Medications Dipyridamole for Preventing Stroke and Other Vascular Events in Patients With Vascular Disease: An Update (Schryver, Algra and Gijn 2008)

Discontinuation of Anticonvulsants Studies show that the rate of seizure recurrence after AED withdrawal is about two to three times the rate in patients who continue AEDs ED discontinuation may be considered in patients whose seizures have been completely controlled for a prolonged period – 1 to 2 years for children & 2 to 5 years for adults Hixson, John. "Stopping Antiepileptic Drugs." Current Treatment Options in Neurology (Springerlink), 12, no 5 (June 2010):

Discontinuation of Anticonvulsants Factors such known to increase risk of recurrence longer duration of epilepsy an abnormal neurologic examination an abnormal EEG – In patients with a favorable prognosis, risk of relapse can be as high as 20% to 25% – Before withdrawing AEDs, patients should be counseled about their individual risk for relapse and the potential implications of a recurrent seizure, particularly for safety and driving.